Results demonstrate favorable safety profile and clinically meaningful improvements in patients with non-ischemic heart failure
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
IOLCP has reported total income of Rs. 559.06 crores during the period ended June 30, 2025
Takara Bio Europe will distribute MN’s Bioanalysis portfolio in Austria, Belgium, Denmark, France, Germany, Ireland, Luxembourg, Sweden, Switzerland, and the United Kingdom
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Usnoflast has previously also received ‘Orphan Drug Designation (ODD)’ from the USFDA
YESINTEK is indicated for the treatment of adults and children from the age of 6 years and olde
The CDMO upgrade represents a transformational step for Remedium Lifecare
Subscribe To Our Newsletter & Stay Updated
